Immunome (IMNM) Insider Trading & Ownership $12.02 -0.42 (-3.38%) (As of 12/17/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Immunome (NASDAQ:IMNM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.60%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$1.10 MNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$279,313.12 Get IMNM Insider Trade Alerts Want to know when executives and insiders are buying or selling Immunome stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IMNM Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Immunome Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/21/2024Clay B SiegallCEOBuy66,057$9.54$630,183.78 11/21/2024Philip TsaiCTOBuy21,000$9.43$198,030.00 11/21/2024Robert LechleiderInsiderBuy15,805$9.48$149,831.40 9/19/2024Max RosettCFOSell14,380$16.01$230,223.80 8/16/2024Jean Jacques BienaimeDirectorBuy7,000$13.94$97,580.00 8/15/2024Jack HigginsInsiderSell3,524$13.93$49,089.32 5/21/2024Jean Jacques BienaimeDirectorBuy2,000$13.57$27,140.00 (Data available from 1/1/2013 forward) IMNM Insider Trading Activity - Frequently Asked Questions Who is on Immunome's Insider Roster? The list of insiders at Immunome includes Bruce Turner, Clay B Siegall, Jack Higgins, Jean Jacques Bienaime, Max Rosett, Philip Tsai, and Robert Lechleider. Learn more on insiders at IMNM. What percentage of Immunome stock is owned by insiders? 8.60% of Immunome stock is owned by insiders. Learn more on IMNM's insider holdings. Which Immunome insiders have been buying company stock? The following insiders have purchased IMNM shares in the last 24 months: Bruce Turner ($249,993.00), Clay B Siegall ($1,630,179.42), Jean Jacques Bienaime ($124,720.00), Philip Tsai ($198,030.00), and Robert Lechleider ($149,831.40). How much insider buying is happening at Immunome? Insiders have purchased a total of 323,366 IMNM shares in the last 24 months for a total of $2,352,753.82 bought. Which Immunome insiders have been selling company stock? The following insiders have sold IMNM shares in the last 24 months: Jack Higgins ($49,089.32), and Max Rosett ($230,223.80). How much insider selling is happening at Immunome? Insiders have sold a total of 17,904 Immunome shares in the last 24 months for a total of $279,313.12 sold. Immunome Key ExecutivesDr. Clay B. Siegall Ph.D. (Age 63)President, CEO & Chairman Compensation: $1.43MDr. Jack Higgins Ph.D. (Age 44)Chief Scientific Officer Compensation: $956.34kDr. Robert J. Lechleider M.D. (Age 63)Chief Medical Officer Compensation: $512.49k More Insider Trading Tools from MarketBeat Related Companies MRUS Insider Trading TWST Insider Trading ACAD Insider Trading VCEL Insider Trading SWTX Insider Trading KYMR Insider Trading ZLAB Insider Trading GMTX Insider Trading VERA Insider Trading BHC Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:IMNM) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunome, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunome With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
